Minerva Surgical, Inc.

Equities

UTRS

US60343F2056

Medical Equipment, Supplies & Distribution

Market Closed - OTC Markets Other stock markets 11:21:34 2024-04-25 am EDT			5-day change	1st Jan Change
0.001 ^USD	-99.76%		-99.78%	-99.91%

Jan. 03	Minerva Surgical, Inc.(OTCPK:UTRS) dropped from S&P TMI Index	CI
2023	Minerva Surgical, Inc.(OTCPK:UTRS) dropped from NASDAQ Composite Index	CI

Minerva Surgical, Inc. Announces Resignation of Ross A. Jaffe from the Board and from the Compensation Committee of the Board

July 07, 2023 at 04:29 pm EDT

On July 1, 2023, Dr. Ross A. Jaffe, Chairman of the Board of Directors, resigned from the Board and from the compensation committee of the Board of Minerva Surgical, Inc. Dr. Jaffeâ€™s decision to resign was not the result of any disagreement with the policies, procedures or practices of the Company.

Latest news about Minerva Surgical, Inc.

Minerva Surgical, Inc.(OTCPK:UTRS) dropped from S&P TMI Index	Jan. 03	CI
Minerva Surgical, Inc.(OTCPK:UTRS) dropped from NASDAQ Composite Index	Dec. 28	CI
North American Morning Briefing : Stock Futures Edge Up to Start the Week	Dec. 18	DJ
Minerva Surgical, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	Nov. 13	CI
Earnings Flash (UTRS) MINERVA SURGICAL Reports Q3 Revenue $12M	Nov. 13	MT
Minerva Surgical, Inc. cancelled the transaction announced on September 28, 2023	Oct. 31	CI
Minerva Surgical, Inc. announced that it expects to receive $20 million in funding from Accelmed Partners	23-09-27	CI
Transcript : Minerva Surgical, Inc., Q2 2023 Earnings Call, Aug 02, 2023	23-08-02
Minerva Surgical, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23-08-02	CI
Earnings Flash (UTRS) MINERVA SURGICAL Posts Q2 Revenue $13.4M	23-08-02	MT
Minerva Surgical, Inc. Provides Earnings Guidance for the Fiscal Year 2023	23-08-02	CI
Minerva Surgical, Inc. Announces Resignation of Ross A. Jaffe from the Board and from the Compensation Committee of the Board	23-07-07	CI
Minerva Surgical, Inc.(NasdaqCM:UTRS) dropped from Russell 3000E Index	23-06-23	CI
Minerva Surgical, Inc.(NasdaqCM:UTRS) dropped from Russell Microcap Index	23-06-23	CI
Minerva Surgical, Inc.(NasdaqCM:UTRS) dropped from Russell Microcap Growth Index	23-06-23	CI
Minerva Surgical, Inc.(NasdaqCM:UTRS) dropped from Russell 3000E Growth Index	23-06-23	CI
Sector Update: Health Care Stocks Decline	23-05-24	MT
Sector Update: Health Care Stocks Lower on Wednesday Afternoon	23-05-24	MT
Minerva Surgical Gets US Patent for Medical System for Tissue Extraction, Resection; Shares Jump	23-05-24	MT
Wall Street Set to Open Lower as Investors Await Progress on Debt-Ceiling Talks Ahead of Fed Minutes Release	23-05-24	MT
US Futures Lower as Investors Eye Debt Ceiling Talks, Await Fed Minutes Release	23-05-24	MT
Top Premarket Gainers	23-05-24	MT
Piper Sandler Adjusts Minerva Surgical's Price Target to $1 From $5, Keeps Overweight Rating	23-05-03	MT
Transcript : Minerva Surgical, Inc., Q1 2023 Earnings Call, May 02, 2023	23-05-02
Minerva Surgical, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023	23-05-02	CI

Chart Minerva Surgical, Inc.

Duration

Period

More charts

Company Profile

Minerva Surgical, Inc. is a commercial-stage medical technology company focused on developing, manufacturing, and commercializing minimally invasive solutions to meet the distinct uterine healthcare needs of women. It has established a product line of commercially available, minimally invasive alternatives to hysterectomy, which are designed to address the most common causes of Abnormal Uterine Bleeding (AUB) in most uterine anatomies. Its Minerva Surgical solutions can be used in a variety of medical treatment settings and aim to address the drawbacks associated with alternative treatment methods and to preserve the uterus by avoiding unnecessary hysterectomies. It offers a range of solutions, such as the Minerva ES Endometrial Ablation System (Minerva ES), Genesys HTA Endometrial Ablation System (Genesys HTA), Symphion Tissue Removal System (Symphion), and Resectr Tissue Resection Device (Resectr). Minerva ES is an endometrial ablation device that utilizes its PlasmaSense technology.

Sector

Medical Equipment, Supplies & Distribution

Calendar

2024-05-07 - Q1 2024 Earnings Release (Projected)

More about the company

	1st Jan change	Capi.
MINERVA SURGICAL, INC.	-99.91%	8.88K
STRYKER CORPORATION	+12.07%	128B
SMITH & NEPHEW PLC	-9.04%	10.65B
IMEIK TECHNOLOGY DEVELOPMENT CO.,LTD.	+0.91%	8.82B
INSPIRE MEDICAL SYSTEMS, INC.	+16.72%	7.19B
GLAUKOS CORPORATION	+25.15%	4.99B
AXONICS, INC.	+7.17%	3.4B
ENOVIS CORPORATION	-1.36%	3.03B
BEIJING BALANCE MEDICAL TECHNOLOGY CO.,LTD.	-8.73%	2.14B
SHANGHAI MICROPORT ENDOVASCULAR MEDTECH CO., LTD.	-10.15%	2B

Medical Devices & Implants